Product Portfolio

Antimicrobial resistance

Protecting progress, pushing for more appropriate prescribing

Antimicrobial resistance is an ever-evolving threat to human health—stemming from the widespread and inappropriate use of antibiotics.

Diagnosing infections based on the presentation of clinical signs & symptoms often results in antibiotics being inappropriately prescribed, putting added pressure onto already strained health systems. The ability to generate confident results quickly can enable earlier initiation of appropriate treatment if treatment is required at all.

Roche’s diagnostic portfolio allows for the adoption of different strategies to cover a range of scenarios—from detecting pathogens early for decreased transmission to supporting antimicrobial stewardship efforts.

View products

Found 0 results in